Clinical Trial Update: Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer [Phase 1]

View source ↗

Summary

A Phase I dose-escalation trial evaluating stereotactic radiosurgical boost for locally advanced esophageal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Stanford University | Conditions: Esophageal Neoplasms, Carcinoma, Squamous Cell | Phase 1 | Status: TERMINATED